Bahl & Gaynor Inc. Acquires 9,436 Shares of Amdocs Limited (NASDAQ:DOX)

→ Gold Mania (From Stansberry Research) (Ad)

Bahl & Gaynor Inc. raised its stake in shares of Amdocs Limited (NASDAQ:DOX - Free Report) by 2.6% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 377,316 shares of the technology company's stock after buying an additional 9,436 shares during the period. Bahl & Gaynor Inc. owned approximately 0.32% of Amdocs worth $33,162,000 as of its most recent SEC filing.

Several other large investors have also recently bought and sold shares of the stock. Allspring Global Investments Holdings LLC boosted its position in shares of Amdocs by 1.5% during the 3rd quarter. Allspring Global Investments Holdings LLC now owns 4,962,197 shares of the technology company's stock valued at $419,256,000 after purchasing an additional 75,733 shares in the last quarter. Invesco Ltd. boosted its position in shares of Amdocs by 31.0% during the 3rd quarter. Invesco Ltd. now owns 2,629,346 shares of the technology company's stock valued at $222,153,000 after purchasing an additional 621,962 shares in the last quarter. Nordea Investment Management AB boosted its holdings in shares of Amdocs by 1.9% in the third quarter. Nordea Investment Management AB now owns 2,109,185 shares of the technology company's stock worth $180,905,000 after buying an additional 38,452 shares during the period. American Century Companies Inc. boosted its holdings in shares of Amdocs by 6.2% in the third quarter. American Century Companies Inc. now owns 1,980,219 shares of the technology company's stock worth $167,309,000 after buying an additional 115,744 shares during the period. Finally, Wellington Management Group LLP boosted its holdings in shares of Amdocs by 5.7% in the third quarter. Wellington Management Group LLP now owns 1,289,317 shares of the technology company's stock worth $108,934,000 after buying an additional 69,825 shares during the period. Institutional investors and hedge funds own 92.02% of the company's stock.


Analyst Upgrades and Downgrades

Several research analysts have commented on DOX shares. Citigroup raised their target price on shares of Amdocs from $96.00 to $104.00 and gave the stock a "buy" rating in a report on Wednesday, January 17th. Barclays raised their price target on shares of Amdocs from $105.00 to $115.00 and gave the stock an "overweight" rating in a report on Thursday, February 8th. Finally, StockNews.com cut shares of Amdocs from a "strong-buy" rating to a "buy" rating in a report on Friday, March 15th. Five analysts have rated the stock with a buy rating, Based on data from MarketBeat, Amdocs has a consensus rating of "Buy" and a consensus price target of $108.60.

Check Out Our Latest Research Report on Amdocs

Amdocs Stock Down 0.8 %

DOX traded down $0.66 during midday trading on Friday, hitting $84.98. 575,911 shares of the company's stock traded hands, compared to its average volume of 493,415. The company has a market cap of $9.99 billion, a PE ratio of 18.20, a price-to-earnings-growth ratio of 1.39 and a beta of 0.69. The stock's fifty day simple moving average is $89.62 and its 200-day simple moving average is $87.34. The company has a debt-to-equity ratio of 0.21, a current ratio of 1.29 and a quick ratio of 1.29. Amdocs Limited has a one year low of $78.38 and a one year high of $99.75.

Amdocs (NASDAQ:DOX - Get Free Report) last issued its quarterly earnings data on Tuesday, February 6th. The technology company reported $1.56 earnings per share for the quarter, beating the consensus estimate of $1.40 by $0.16. Amdocs had a net margin of 11.30% and a return on equity of 17.79%. The firm had revenue of $1.25 billion for the quarter, compared to analyst estimates of $1.24 billion. During the same quarter last year, the firm earned $1.33 earnings per share. The company's revenue for the quarter was up 5.0% on a year-over-year basis. As a group, equities analysts anticipate that Amdocs Limited will post 5.87 earnings per share for the current fiscal year.

Amdocs Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, April 26th. Stockholders of record on Friday, March 29th were given a $0.479 dividend. This is a positive change from Amdocs's previous quarterly dividend of $0.44. The ex-dividend date of this dividend was Wednesday, March 27th. This represents a $1.92 dividend on an annualized basis and a dividend yield of 2.25%. Amdocs's dividend payout ratio (DPR) is currently 41.11%.

About Amdocs

(Free Report)

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.

Recommended Stories

Institutional Ownership by Quarter for Amdocs (NASDAQ:DOX)

→ Gold Set to EXPLODE! (From Gold Safe Exchange) (Ad)

Should you invest $1,000 in Amdocs right now?

Before you consider Amdocs, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amdocs wasn't on the list.

While Amdocs currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2024 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Featured Articles and Offers

Search Headlines: